Inducible HEK293 AAV packaging cell lines expressing Rep proteins
Molecular Therapy - Methods & Clinical Development · 2023-09 · 30 · 259-275
DOI: 10.1016/j.omtm.2023.07.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy - Methods & Clinical Development, 2023-09. Verfasst von Lovro Jalšić und 7 weiteren Autor:innen. Beteiligte Einrichtung: Département de Génie Chimique, Université Laval, Québec, QC G1V0A6, Canada. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Council Canada, Fonds de Recherche du Québec - Santé, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Packaging or producer cell lines for scalable recombinant adeno-associated virus (rAAV) production have been notoriously difficult to create due in part to the cytostatic nature of the Rep proteins required for AAV production. The most difficult challenge being creating AAV packaging cell lines using HEK293 parental cells, currently the best mammalian platform for rAAV production due to the constitutive expression of E1A in HEK293 cells, a key REP transcription activator. Using suspension and serum-free media adapted HEK293SF carrying a gene expression regulation system induced by addition of cumate and coumermycin, we were able to create REP-expressing AAV packaging cells. This was achieved by carefully choosing two of the AAV Rep proteins (Rep 40 and 68), using two inducible promoters with different expression levels and integrating into the cells through lentiviral vector transduction. Three of our best clones produced rAAV titers comparable to titers obtained by standard triple plasmid transfection of their parental cells. These clones were stable for up to 7 weeks under continuous cultures condition. rAAV production from one clone was also validated at scale of 1 L in a wave bioreactor using serum-free suspension culture.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Département de Génie Chimique, Université Laval, Québec, QC G1V0A6, Canada.
- Department of Production Platforms and Analytics, Human Health Therapeutics Research Center, National Research Council Canada, Montréal, QC H4P 2R2, Canada.
- Advanced Biomaterials and Chemical Synthesis Team, Aquatic and Crop Resource Development Research Centre, National Research Council Canada, Montréal, QC H4P 2R2, Canada.
- Department of Bioengineering, McGill University, Montréal, QC H3A 0E9 Canada.
Förderung
- National Research Council Canada
- Fonds de Recherche du Québec - Santé
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Jalšić, L., Lytvyn, V., Elahi, S. M., Hrapovic, S., Nassoury, N., Chahal, P. S., Gaillet, B., & Gilbert, R. (2023). Inducible HEK293 AAV packaging cell lines expressing Rep proteins. Molecular Therapy - Methods & Clinical Development, 30, 259-275. https://doi.org/10.1016/j.omtm.2023.07.002
Vancouver
Jalšić L, Lytvyn V, Elahi SM, Hrapovic S, Nassoury N, Chahal PS, et al. Inducible HEK293 AAV packaging cell lines expressing Rep proteins. Molecular Therapy - Methods & Clinical Development. 2023;30:259-275. doi:10.1016/j.omtm.2023.07.002
BibTeX
@article{Jali2023,
author = {Jalšić, Lovro and Lytvyn, Viktoria and Elahi, Seyyed Mehdy and Hrapovic, Sabahudin and Nassoury, Nasha and Chahal, Parminder Singh and Gaillet, Bruno and Gilbert, Rénald},
title = {Inducible HEK293 AAV packaging cell lines expressing Rep proteins},
journal = {Molecular Therapy - Methods & Clinical Development},
year = {2023},
volume = {30},
pages = {259--275},
doi = {10.1016/j.omtm.2023.07.002}
}
EUVIMED